The Whys and Wherefores of Antibiotic Resistance - PubMed (original) (raw)
Review
The Whys and Wherefores of Antibiotic Resistance
Cameron R Strachan et al. Cold Spring Harb Perspect Med. 2017.
Abstract
The development and rapid dissemination of antibiotic-resistant bacterial pathogens has tarnished the dream of a world without infectious diseases. However, our understanding of these processes, paired with sequence information from terrestrial bacterial populations, indicates that there is no shortage of novel natural products that could be developed into new medicines. Regardless, their therapeutic success in the clinic will depend on the introduction of mandatory controls and use restrictions.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.
Similar articles
- Resistant pathogens: considerations in geriatrics and infectious disease.
Yoshikawa TT. Yoshikawa TT. J Am Geriatr Soc. 2002 Jul;50(7 Suppl):S225. doi: 10.1046/j.1532-5415.50.7s.1.x. J Am Geriatr Soc. 2002. PMID: 12121516 No abstract available. - Infectious disease 2001: drug resistance, new drugs.
Georgopapadakou NH. Georgopapadakou NH. Drug Resist Updat. 2002 Oct;5(5):181-91. doi: 10.1016/s1368-7646(02)00088-2. Drug Resist Updat. 2002. PMID: 12450783 - Key pathogens and emerging therapies in infectious diseases.
Miller PF, Mueller JP. Miller PF, et al. Curr Opin Pharmacol. 2009 Oct;9(5):535-6. doi: 10.1016/j.coph.2009.09.001. Epub 2009 Sep 18. Curr Opin Pharmacol. 2009. PMID: 19766536 No abstract available. - Selection of antibiotic-resistant pathogens in the community.
Yagupsky P. Yagupsky P. Pediatr Infect Dis J. 2006 Oct;25(10):974-6. doi: 10.1097/01.inf.0000239270.33190.71. Pediatr Infect Dis J. 2006. PMID: 17006309 Review.
Cited by
- Medicinal Properties and Bioactive Compounds from Wild Mushrooms Native to North America.
Zeb M, Lee CH. Zeb M, et al. Molecules. 2021 Jan 6;26(2):251. doi: 10.3390/molecules26020251. Molecules. 2021. PMID: 33419035 Free PMC article. Review. - Antimicrobial resistance mechanisms and potential synthetic treatments.
Ali J, Rafiq QA, Ratcliffe E. Ali J, et al. Future Sci OA. 2018 Feb 5;4(4):FSO290. doi: 10.4155/fsoa-2017-0109. eCollection 2018 Apr. Future Sci OA. 2018. PMID: 29682325 Free PMC article. Review. - Antibiotics targeting bacterial ribosomal subunit biogenesis.
Champney WS. Champney WS. J Antimicrob Chemother. 2020 Apr 1;75(4):787-806. doi: 10.1093/jac/dkz544. J Antimicrob Chemother. 2020. PMID: 31942624 Free PMC article. Review. - Blue light directly modulates the quorum network in the human pathogen Acinetobacter baumannii.
Tuttobene MR, Müller GL, Blasco L, Arana N, Hourcade M, Diacovich L, Cribb P, Tomás M, Nieto-Peñalver CG, Mussi MA. Tuttobene MR, et al. Sci Rep. 2021 Jun 28;11(1):13375. doi: 10.1038/s41598-021-92845-1. Sci Rep. 2021. PMID: 34183737 Free PMC article. - Light Modulates Important Pathogenic Determinants and Virulence in ESKAPE Pathogens Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus.
Tuttobene MR, Pérez JF, Pavesi ES, Perez Mora B, Biancotti D, Cribb P, Altilio M, Müller GL, Gramajo H, Tamagno G, Ramírez MS, Diacovich L, Mussi MA. Tuttobene MR, et al. J Bacteriol. 2021 Feb 8;203(5):e00566-20. doi: 10.1128/JB.00566-20. Print 2021 Feb 8. J Bacteriol. 2021. PMID: 33288627 Free PMC article.
References
- Abraham EP, Chain E. 1988. An enzyme from bacteria able to destroy penicillin. 1940. Rev Infect Dis 10: 677–678. - PubMed
- Ashton PM, Satheesh N, Dallman T, Rubino S, Rabsch W, Mwaigwisya S, Wain J, O’Grady J. 2015. MinION nanopore sequencing identifies the position and structure of a bacterial antibiotic resistance island. Nat Biotechnol 33: 296–300. - PubMed
- Colwell RR. 1997. Microbial diversity: The importance of exploration and conservation. J Ind Microbiol Biotechnol 18: 302–307. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical